Advertisement

More insurers covering use of Uroplasty device

July 18, 2011 at 3:07PM

Uroplasty Inc. said Monday two additional private insurance plans will now cover its nerve stimulation device system to treat symptoms of overactive bladder.

The Plymouth-based medical device company said Health Care Service Corp., which covers about 13 million people in Texas, Illinois, New Mexico and Oklahoma, will cover the Urgent PC Neuromodulation System effective Aug. 1. In addition, Blue Cross Blue Shield of Nebraska, which covers 668,000 people, initiated coverage of the system beginning May 18.

David Kaysen, president and CEO of Uroplasty, said the company has secured insurance coverage from three of the four largest private payers in the United States for the system which zaps the tibial nerve in the ankle to treat overactive bladder.

Janet Moore • 612-673-7752

Advertisement
about the writer

about the writer

Janet Moore

Reporter

Transportation reporter Janet Moore covers trains, planes, automobiles, buses, bikes and pedestrians. Moore has been with the Star Tribune for 21 years, previously covering business news, including the retail, medical device and commercial real estate industries. 

See Moreicon

More from Business

See More
The United States Capitol, Washington, DC.

Medtronic, Abbott Laboratories and Boston Scientific all increased lobbying by at least $100,000 for the first quarter of year.

card image
card image
Advertisement
Advertisement

To leave a comment, .

Advertisement